CTL priming by CD8(+) and CD8(-) dendritic cells in vivo. by Ruedl, C, Bachmann, M

The antigen dose determines T helper subset development by regulation of CD40 ligand. by Ruedl, C, Bachmann, M, Kopf, M

CD8(+) T cells mediate CD40-independent maturation of dendritic cells in vivo. by Ruedl, C, Kopf, M, Bachmann, M

Cross-presentation of virus-like particles by skin-derived CD8(-) dendritic cells: a dispensable role for TAP. by Ruedl, C, Storni, T, Lechner, F, Bächi, T, Bachmann, M

Rapid response of marginal zone B cells to viral particles. by Gatto, D, Ruedl, C, Odermatt, B, Bachmann, M

Anatomical origin of dendritic cells determines their life span in peripheral lymph nodes. by Ruedl, C, Koebel, P, Bachmann, M, Hess, M, Karjalainen, K

Virus-like particles as carriers for T-cell epitopes: limited inhibition of T-cell priming by carrier-specific antibodies. by Ruedl, C, Schwarz, K, Jegerlehner, A, Storni, T, Manolova, V, Bachmann, M

Critical role for activation of antigen-presenting cells in priming of cytotoxic T cell responses after vaccination with virus-like particles. by Storni, T, Lechner, F, Erdmann, I, Bächi, T, Jegerlehner, A, Dumrese, T, Kündig, T, Ruedl, C, Bachmann, M

OX40-deficient mice are defective in Th cell proliferation but are competent in generating B cell and CTL Responses after virus infection. by Kopf, M, Ruedl, C, Schmitz, N, Gallimore, A, Lefrang, K, Ecabert, B, Odermatt, B, Bachmann, M

The human membrane cofactor CD46 is a receptor for species B adenovirus serotype 3. by Sirena, D, Lilienfeld, B, Eisenhut, M, Kälin, S, Boucke, K, Beerli, R, Vogt, L, Ruedl, C, Bachmann, M, Greber, U, Hemmi, S

A high-throughput alphavirus-based expression cloning system for mammalian cells. by Koller, D, Ruedl, C, Loetscher, M, Vlach, J, Oehen, S, Oertle, K, Schirinzi, M, Deneuve, E, Moser, R, Kopf, M, Bailey, J, Renner, W, Bachmann, M

CCL19 and CCL21 induce a potent proinflammatory differentiation program in licensed dendritic cells. by Marsland, B, Bättig, P, Bauer, M, Ruedl, C, Lässing, U, Beerli, R, Dietmeier, K, Ivanova, L, Pfister, T, Vogt, L, Nakano, H, Nembrini, C, Saudan, P, Kopf, M, Bachmann, M

Targeting mutated plus germline epitopes confers pre-clinical efficacy of an instantly formulated cancer nano-vaccine by Mohsen, M, Vogel, M, Riether, C, Muller, J, Salatino, S, Ternette, N, Gomes, A, Cabral-Miranda, G, El-Turabi, A, Ruedl, C, Kundig, T, Dermime, S, Knuth, A, Speiser, D, Bachmann, M